Saline Injection
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Fasciitis, Plantar
Conditions
Fasciitis, Plantar
Trial Timeline
Jan 8, 2018 → Mar 17, 2021
NCT ID
NCT03414268About Saline Injection
Saline Injection is a phase 3 stage product being developed by MiMedx Group for Fasciitis, Plantar. The current trial status is completed. This product is registered under clinical trial identifier NCT03414268. Target conditions include Fasciitis, Plantar.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03414268 | Phase 3 | Completed |
| NCT02427191 | Phase 2/3 | Completed |
Competing Products
3 competing products in Fasciitis, Plantar
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Daptomycin 6mg/kg/day | Merck | Pre-clinical | 23 |
| Botulinum toxin type A + Placebo | Ipsen | Phase 2/3 | 62 |
| Saline Injection | MiMedx Group | Phase 2/3 | 60 |